AtriCure Inc
-
Business
Which stocks might be disrupted next by Ozempic and other GLP-1 drugs
Shares of kidney dialysis providers fell sharply Wednesday after Novo Nordisk said a study showed its Ozempic drug could delay…
Read More »
Shares of kidney dialysis providers fell sharply Wednesday after Novo Nordisk said a study showed its Ozempic drug could delay…
Read More »Hedge funds like Bill Ackman’s Pershing Square and Seth Klarman’s Baupost usually get all the attention, but some of the…
Read More »